UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

 

FORM 8-K

 

 

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

Date of report (Date of earliest event reported): December 15, 2016

 

ADVAXIS, INC.

(Exact Name of Registrant as Specified in Charter)

 

Delaware   000-30929   13-4087132

(State or Other Jurisdiction

of Incorporation)

   (Commission File
Number)		   (IRS Employer
Identification No.)

 

305 College Road

Princeton, New Jersey 08540

(Address of Principal Executive Offices)

 

(609) 452-9813

(Registrant’s telephone number, including area code)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

  [  ] Written communications pursuant to Rule 425 under the Securities Act.
     
  [  ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act.
     
  [  ] Pre-commencement communications pursuant to Rule 14d-2b under the Exchange Act.
     
  [  ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.

 

 

 

   
 

 

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

The Company is announcing that Gregory T. Mayes, Executive Vice President and Chief Business Officer, has resigned from the Company in order to pursue a business opportunity focused on the development of a treatment for epileptic seizures, a condition that affects an immediate family member. The resignation will be effective as of December 30, 2016. Mr. Mayes will continue to serve as a Director on the Company’s Board of Directors.

 

The Company is also announcing the promotion of Sara Bonstein, the Company’s Chief Financial Officer, to Executive Vice President. The promotion will be effective as of December 30, 2016.

 

 - 2 - 
 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  Advaxis, Inc.
  (Registrant)
     
Date: December 15, 2016    
     
  By: /s/ Daniel O’Connor
    Daniel O’Connor
    President and Chief Executive Officer

 

 - 3 -